Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors

Lingyue Zhaoa Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China;b Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, ChinaView further author information

Qian Yanga Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China;b Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, ChinaView further author information

Yiqun Tangc Department of Clinical Pharmacy, School of Basic Medical Sciences and Clinical Pharmacy, China Pharmaceutical University, Nanjing, ChinaView further author information

Qidong Youa Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China;b Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, ChinaCorrespondence[email protected]
View further author information

Xiaoke Guoa Jiang Su Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China;b Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, ChinaCorrespondence[email protected]
View further author information

Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Design, synthesis, and biological evaluation of arylmethylpiperidines as Kv1.5 potassium channel inhibitors

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date